The "Muenster classification" of high frequency hearing loss following cisplatin chemotherapy;Die "Münsteraner klassifikation". Eine neue einteilung der hochtonschwerhörigkeit nach cisplatingabe

HNO

Volumn 55, Issue 4, 2007, Pages 299-306

  Schmidt, C M ^a   Bartholomaus E ^a   Deuster, D ^a   Heinecke, A ^b   Dinnesen, A G ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b Koordinierungszentrum für Klinische Studien ^*  (Germany)

Author keywords

Audiometry; Children; Cisplatin; Classification; High frequency hearing loss

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN;

ADOLESCENT; CHEMICALLY INDUCED DISORDER; CHILD; CLASSIFICATION; CLINICAL TRIAL; DRUG EFFECT; FEMALE; HEARING; HEARING LOSS; HOSPITALIZATION; HUMAN; MALE; METHODOLOGY; PRESCHOOL CHILD; PURE TONE AUDIOMETRY; REPRODUCIBILITY; REVIEW; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ANTINEOPLASTIC AGENTS; AUDIOMETRY, PURE-TONE; CHILD; CHILD, PRESCHOOL; CISPLATIN; FEMALE; HEARING LOSS; HUMANS; MALE; PITCH PERCEPTION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 34247244292     PISSN: 00176192     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00106-005-1368-1     Document Type: Review

References (20)

1. Langer T, Stohr W, Bielack S, Paulussen M, Treuner J, Beck JD (2004) Late effects surveillance system for sarcoma patients. Pediatr Blood Cancer 42: 373-379
2. Simon T, Hero B, Dupuis W, Selle B, Berthold F (2002) The incidence of hearing impairment after successful treatment of neuroblastoma. Klin Paediatr 214: 149-152
3. Brock PR, Bellman SC, Yeomans EC, Pinkerton CR, Pritchard J (1991) Cisplatin ototoxicity in children: a practical grading system. Med Pediatr Oncol 19: 295-300
4. Huang E, Teh BS, Strother DR et al. (2002) Intensity modulated radiation therapy for pediatric medulloblastoma: Early report on the reduction of ototoxicity. Int J Radiation Oncology Biol Phys 52: 599-605
5. Schell MJ, McHaney VA, Green AA, Kun LE, Hayes FA, Horowitz M, Meyer WH (1989) Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation. J Clin Oncol 7: 754-760
6. Ilveskoski I, Saarinen UM, Wiklund T et al. (1996) Ototoxicity in children with malignant brain tumors treated with the "8 in 1" chemotherapy protocol. Med Pediatr Oncol 27: 26-31
7. Ruiz L, Gilden J, Jaffe N, Robertson R, Wang YM (1989) Auditory function in pediatric ostosarcoma patients treated with multiple doses of cis-diamminedichloroplatinum II. Cancer Res 49: 742-744
8. Komune S, Sukamas A, Snow JB (1981) Pathophysiology of the ototoxicity of cis-diamminedichloroplatinum. Ototlaryngol Head Neck Surg 89: 275-282
9. Tange RA, Vuszevski VD (1984) Changes in the stria vascularis of the guniea pig due to cis- platinum. Arch Otorhinolaryngol 239: 41-47
10. Tsukasaki N, Withworth CA, Rybak LP (2000) Acute changes in cochlear potentials due to cisplatin. Hear Res 149: 189-198
11. Kaltenbach JA, Rachel JD, Mathog TA, Zhang J, Falzarano PR, Lewandowski M (2002) Cisplatin-induced hyperactivity in the dorsal cochlear nucleus and its relation to outer hair cell loss: relevance to tinnitus. J Neurophysiol 88: 699-714
12. Bokemeyer C, Berger CC, Hartmann JT, Kollmannsberger C, Schmoll HJ, Kuczyk MA, Kanz L (1998) Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer. Br J Cancer 77: 1355-1362
13. Black FO, Gianna-Poulin C, Pesznecker SC (2001) Recovery from vestibular ototoxicity. Otol Neurotol 22: 662-671
14. Sergi B, Ferraresi A, Troiani D, Paludetti G, Fetoni AR (2003) Cisplatin ototoxicity in the guinea pig: vestibular and cochlear damage. Hear Res 182: 56-64
15. Prim MP, de Diego JI, de Sarria MJ, Gavilan J (2001) Vestibular and oculomotor changes in subjects treated with cisplatin. Acta Otorrinolaringol Esp 52: 367-370
16. Stelmachowicz PG, Pittman AL, Hoover BM, Lewis DE, Moeller MP (2004) The importance of high-frequency audibility in the speech and language development of children with hearing loss. Arch Otolaryngol Head Neck Surg 130: 556-562
17. Reuter W, Schönfeld U, Fischer R, Gross M (1997) Höruntersuchungen im erweiterten Hochtonbereich bei Kindern im Vorschulalter. HNO 45: 147-152
18. Janssen T (2005) Diagnostik des kochleären Verstärkers mit DPOAE-Wachstumsfunktionen. HNO 53: 121-133
19. Report of the Informal Working Group of Prevention of Deafness and Hearing Impairment Programme Planning WHO, Geneva, 1991. Provided by Smith A. Prevention of Deafness and Hearing Impairment, WHO, Geneva, Switzerland
20. Khan AB, D'Souza BJ, Wharam MD et al. (1982) Cisplatin therapy in recurrent childhood brain tumors. Cancer Treat Rep 66: 2013-2020